Landscapes / Targets
CD7
7 drugs act on CD7, in 8 active trials · Any stage · updated 18 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs7
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 2 | 30 Dec 2026Phase 2 trial completes | |||
| Next date | 30 Dec 2026 · Phase 2 trial completes | ||||
| Also tested for | T-cell Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma | ||||
| Open drug page | |||||
— |
Phase 1/2 | Dec 2026Phase 1/2 trial completes | |||
| Next date | Dec 2026 · Phase 1/2 trial completes | ||||
| Also tested for | Lymphoblastic Lymphoma, T-Cell Lymphoblastic Leukemia/Lymphoma and 1 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | 14 Mar 2027Phase 1/2 trial completes | |||
| Next date | 14 Mar 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia, Relapsed/Refractory B-cell Non-Hodgkin Lymphoma or CLL/SLL and 5 more | ||||
| Open drug page | |||||
— |
Phase 2 | — | |||
| Also tested for | T Lymphoblastic Leukemia/Lymphoma | ||||
| Open drug page | |||||
— |
Phase 2 | — | |||
| Also tested for | CD7-positive Relapsed/Refractory T Lymphoblastic Leukemia/Lymphoma, CD7+ T-ALL/LBL | ||||
| Open drug page | |||||
In vivo CAR-T (CD19, BCMA and CD70 CARs), lentiviral |
Early Phase 1 | 30 May 2029Early Phase 1 trial completes | |||
| How it works | Reprograms the patient's own immune T cells | ||||
| Next date | 30 May 2029 · Early Phase 1 trial completes | ||||
| Also tested for | Relapsed or Refractory Acute Leukemia, Relapsed or Refractory Acute Lymphoblastic Leukemia and 1 more | ||||
| Open drug page | |||||
SENL101not checked |
— |
Phase 1 | — | ||
| Also tested for | T-lymphoblastic Lymphoma, T-ALL | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 6 of 7 drugs. The other 1 is marked “not checked” in the list. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026